Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) A substudy of the phase 2 obesity trial specifically examined GLP3 s effects on liver fat in participants with metabolic dysfunction-associated steatotic liver disease[12]: Mean relative liver fat reduction of 82.4% with 12 mg dose at 24 weeks 86% of participants on 12 mg achieved normal liver fat levels (below 5%) at 24 weeks Liver fat reductions significantly correlated with improvements in insulin sensitivity, abdominal fat, and metabolic parameters Dose-dependent improvements observed across all dose groups compared to placebo These results suggest potential therapeutic applications beyond weight management, addressing hepatic complications of obesity and metabolic syndrome
Weekly Injections: From $69 Monthly Cost: From $279 2.5-Month (10 Weeks): $449 5-Month (20 Weeks): $749 Disclaimer: Dosage and pricing may vary based on medical evaluation
By engaging these three hormonal pathways, retatrutide is intended to improve metabolic homeostasis by modulating glucose regulation, suppressing appetite, and increasing energy expenditure
Wang H, Zhu C, Ying Y, Luo L, Huang D, Luo Z
Is there a catch
Step three: medical history